Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
05/07/2003 | EP1307204A1 Protease inhibitors |
05/07/2003 | EP1307203A1 Protease inhibitors |
05/07/2003 | EP1307195A2 Medicaments containing cilansetron for treating non-obstipated male ibs patients |
05/07/2003 | EP1307108A2 Oil/fat composition |
05/07/2003 | EP1216043B1 Retard form containing alpha-lipoic acid (derivatives) |
05/07/2003 | EP1200106B1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement |
05/07/2003 | EP1147110B1 Pyrazino(aza)indole derivatives |
05/07/2003 | EP1131326B1 Phospholipid derivatives of non-steroidal anti-inflammatory drugs |
05/07/2003 | EP1112251B1 Azetidine derivatives, preparation and medicines containing them |
05/07/2003 | EP1109532A4 Oral micro-emulsion composition of silybin |
05/07/2003 | EP1107775B1 Composition containing pyrrolizidine-alkaloid-free petasites |
05/07/2003 | EP1095036B1 Cinnamic acid derivatives as cell adhesion molecules |
05/07/2003 | EP1058681B1 Novel allylthiopyridazine derivatives and process for preparing the same |
05/07/2003 | EP1045822B1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments |
05/07/2003 | EP0954281B1 Moistening preparation |
05/07/2003 | EP0885190B1 N-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties |
05/07/2003 | EP0874621B1 [3'-DESOXY-3-OXO-MeBmT]1-[Val]2-CICLOSPORIN-CONTAINING EMULSION PHARMACEUTICAL COMPOSITIONS |
05/07/2003 | EP0841929B1 Quinolones and their therapeutic use |
05/07/2003 | EP0831893B1 Regulation of neutrophil elastase synthesis and release |
05/07/2003 | EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
05/07/2003 | EP0709386B1 Fused benzazepine derivative and pharmaceutical composition containing the same |
05/07/2003 | CN1416432A Use of CD25 binding molecules in triatment of inflammatory diseases of gastro-intestinal tract |
05/07/2003 | CN1416428A Compounds having antitumor activity: process for their prepn.and pharmaceutical compsns. contg. them |
05/07/2003 | CN1416425A 1,5-bemzothiazepines and their use as hypolipidaemics |
05/07/2003 | CN1416421A New CCRS modulators: benzimidazoles or benzotriazoles |
05/07/2003 | CN1416347A Agent for treating hepatitis C |
05/07/2003 | CN1416346A Peotease inhibitors |
05/07/2003 | CN1416339A IL-8 receptor antagonsts |
05/07/2003 | CN1415378A Injection of freeze-dried powder of growth hormone release inhibiting hormone and its preparation method |
05/07/2003 | CN1415370A Medicament for curing stomach-ache |
05/07/2003 | CN1415361A Chinese medical preparation for curing cholecystitis |
05/07/2003 | CN1415359A Health foods for tonification, being sturdy and postponing senility |
05/07/2003 | CN1415358A Medicament for curing lithiasis. |
05/07/2003 | CN1415353A Formula of Chinese herbal medicine for curing lithiasis |
05/07/2003 | CN1415352A Formula of medicament for curing lithiasis |
05/07/2003 | CN1415341A Anti-disease grain of ginseng and astragalus root |
05/07/2003 | CN1415338A medicament for curing diarrhea |
05/07/2003 | CN1415336A Drop pills for toothache |
05/07/2003 | CN1415330A Calm stomach tablet for curing gastric disease |
05/07/2003 | CN1415327A Pediatric patent Chinese medicine for relieving darrhea and its preparation method |
05/07/2003 | CN1415326A Pediatric medicament for promoting digestion and stimulating the appetite and its preparation method |
05/07/2003 | CN1415325A Chinese traditional medical preparation for activating the spleen-energy, stimulating the appetite, nourishing and restoring qi |
05/07/2003 | CN1415301A Compound recipe formula containing kurarinone prostaglandin E1 and aspirin, its preparation method and application |
05/07/2003 | CN1415293A Alkaloid of matrine category utilized for mainline and its preparation method |
05/07/2003 | CN1415292A Formula for improving water-solubility of armillarisin and its preparation |
05/07/2003 | CN1415286A Antibiotic antiinflammation preparation made from extract product of Yunnan loquat as essential component |
05/07/2003 | CN1107681C Compound of polypeptide as antigen of hepatitis B virus and heat shock protein and its application |
05/07/2003 | CN1107514C Laxative and its prepn. process |
05/07/2003 | CN1107503C Optically pure compoun as medicinal use |
05/07/2003 | CN1107499C Nitric oxide donor compsns. and method for treating anal disorders |
05/06/2003 | USRE38112 Process for improving glucose metabolism, satiety, and nutrient absorption in companion animals |
05/06/2003 | US6559293 Topiramate sodium trihydrate |
05/06/2003 | US6559168 Thiazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes |
05/06/2003 | US6559167 Prodrugs of the pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs have a hydrolyzable arylsulfonyl or heteroarylsulfonyl group attached to the benzimidazole nitrogen. The prodrugs of the invention hydrolyze under |
05/06/2003 | US6559166 A class of phenylsulphonyl derivatives wherein the sulphonyl moiety is also attached to an N-arylalkyl-substituted azetidine, pyrrolidine or piperidine ring are selective antagonists of the human 5-HT2A receptor and are therefore |
05/06/2003 | US6559159 Kappa opioid receptor ligands |
05/06/2003 | US6559131 Fucan increases the expression and/or the activity of a fibroblastic metalloproteinase or that inhibits leukocyte elastase, or both for treating a periodontal pathology or a dermal pathology |
05/06/2003 | US6558708 Administering agonists or antagonists of serotonin, peptide YY, calcitonin gene related peptide, adrenergic and/or opioid receptors |
05/06/2003 | US6558692 Over-coated chewing gum formulations |
05/06/2003 | US6558675 Mutant human hepatitis B viral strain and uses thereof |
05/06/2003 | CA2268166C Pyrrolo[3,2-c]quinoline derivatives containing haloalkoxy group and pharmaceutically acceptable salts thereof |
05/02/2003 | EP1306429A1 Method of screening ptp zeta activity promoter or inhibitor |
05/02/2003 | EP1306376A1 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist |
05/02/2003 | EP1306375A1 Salts of benzimidazole compound and use thereof |
05/02/2003 | EP1306368A2 3,4-dihydro-1H-naphtalene derivatives as a highly selective cyclooxygenase-2 inhibitor |
05/02/2003 | EP1306094A1 Preventives or remedies for obesity or fatty liver |
05/02/2003 | EP1306085A1 2-Cyclohexyl-4-phenyl-1H-imidazole derivatives as ligands for the neuropeptide Y5 receptor |
05/02/2003 | EP1305438A1 Improved virus like particles based on small envelope protein from hepatitis b (hbsag-s) |
05/02/2003 | EP1305425A2 Drug metabolizing enzymes |
05/02/2003 | EP1305404A2 Protein phosphatases |
05/02/2003 | EP1305402A1 Lipo-viro-particle complexes, preparation method and uses |
05/02/2003 | EP1305342A2 Human kininogen d5 domain polypeptides and their use |
05/02/2003 | EP1305319A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
05/02/2003 | EP1305316A2 Azabicyclic derivatives and their therapeutic use |
05/02/2003 | EP1305313A1 Fused heterocyclic derivatives as phosphodiesterase inhibitors |
05/02/2003 | EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
05/02/2003 | EP1305303A1 NOVEL FORM OF (R)- i N /i - 5-METHYL-8-(4-METHYLPIPERAZIN-1-YL)-1,2,3,4-TETRAHYDRO-2-NAPHTHYL]-4-MORPHOLINOBENZAMIDE |
05/02/2003 | EP1305294A2 Imidazolyl derivatives |
05/02/2003 | EP1305293A1 Hexahydro-7-imino-1h-azepin-2-yl-hexanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
05/02/2003 | EP1305291A1 3-substituted isoquinolin-1-yl derivatives |
05/02/2003 | EP1305285A1 N-substituted indoles useful in the treatment of diabetes |
05/02/2003 | EP1305050A2 Improved oral dosage formulations |
05/02/2003 | EP1305036A2 Nutritional composition |
05/02/2003 | EP1305027A2 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer |
05/02/2003 | EP1305024A1 Method for treating fibrotic diseases or other indications ic |
05/02/2003 | EP1223966B1 Use of gdnf for treating corneal defects |
05/02/2003 | EP1221939A4 Ortho ester lipids |
05/02/2003 | EP1200064B1 Delivery system for oral care compositions comprising organosiloxane reins using a removable backing strip |
05/02/2003 | EP1119351B1 Use of catechol derivatives as proteinase inhibitors |
05/02/2003 | EP1070058B1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
05/02/2003 | EP1021171B1 Delayed total release gastrointestinal drug delivery system |
05/02/2003 | EP0988035B1 Caspases and apoptosis |
05/02/2003 | EP0984957B1 Novel form of s-omeprazole |
05/02/2003 | EP0948544B1 Monovalent antibody fragments |
05/02/2003 | EP0939613B1 Mouthwash comprising calcium and phosphate ions in supersaturated solution |
05/02/2003 | EP0929578B1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
05/02/2003 | EP0815130B1 Casein phosphopeptide, casein containing same and process for the preparation thereof |
05/02/2003 | EP0772592B1 1H-INDOLE-1-FUNCTIONAL sPLA 2 INHIBITORS |
05/02/2003 | EP0769964B1 Cck antibodies used to improve feed efficiency |
05/02/2003 | EP0715519B1 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |